Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-06-28 @ 8:35 PM
Study NCT ID:
NCT03617666
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-12
First Post:
2018-07-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Sponsor:
University College, London
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCL /17/0192
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |